Abstract
Objectives
Relative rates of early graft failure and conduit selection in coronary artery bypass
grafting (CABG) surgery remain controversial. Therefore, we sought to determine the
incidence and determinants of graft failure of the left internal mammary artery (LIMA),
radial artery, saphenous vein, and right internal mammary artery (RIMA) 1 year after
CABG surgery.
Methods
A post hoc analysis of the Cardiovascular Outcomes for People Using Anticoagulation
Strategies (COMPASS) CABG study, involving patients from 83 centers in 22 countries.
We completed an analysis of 3480 grafts from 1068 patients who underwent CABG surgery
with complete computed tomography angiography data. The primary outcome was graft
failure as diagnosed by computed tomography angiography 1 year after surgery.
Results
Graft failure occurred in 6.4% (68/1068) for LIMA, 9.9% (9/91) for radial artery,
10.4% (232/2239) for saphenous vein, and 26.8% (22/82) for RIMA grafts. The RIMA had
a greater rate of graft failure (26.8%) than radial artery (9.9%) and veins (10.4%)
(adjusted odds ratio, 2.69; 95% confidence interval, 1.30-5.57; P = .008 and adjusted odds ratio, 2.07; 95% confidence interval, 1.33-3.21; P = .001, respectively).
Conclusions
In this international trial dataset, LIMA and radial artery performed as expected,
whereas vein grafts performed better. However, high rates of RIMA failure are worrisome
and highlight the need for a thorough evaluation of the patency and safety of the
RIMA in CABG surgery.
Graphical abstract
Graphical Abstract
Key Words
Abbreviations and Acronyms:
CABG (coronary artery bypass grafting), CI (confidence interval), COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies), CTA (computed tomography angiography), LAD (left anterior descending artery), LIMA (left internal mammary artery), OR (odds ratio), PREVENT (Project of Ex-Vivo Vein Graft Engineering via Transfection), RA (radial artery), RIMA (right internal mammary artery), ROOBY (Randomized On/Off Bypass), SV (saphenous vein)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of Thoracic and Cardiovascular SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.Lancet. 1994; 344: 563-570
- 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.Circulation. 2011; 124: 2610-2642
- The Society of Thoracic Surgeons clinical practice guidelines on arterial conduits for coronary artery bypass grafting.Ann Thorac Surg. 2016; 101: 801-809
- Bilateral versus single internal-thoracic-artery grafts at 10 years.N Engl J Med. 2019; 380: 437-446
- Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation.Trials. 2006; 7: 7
- Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial—rationale and study protocol.Eur J Cardiothorac Surg. 2017; 52: 1031-1040
- Angiographic outcome of coronary artery bypass grafts: the Radial Artery Database International Alliance.Ann Thorac Surg. 2020; 109: 688-694
- Angiographic patency of coronary artery bypass conduits: a network meta-analysis of randomized trials.J Am Heart Assoc. 2021; 10: e019206
- 2018 ESC/EACTS guidelines on myocardial revascularization.Eur Heart J. 2018; 40: 87-165
- Rivaroxaban with or without aspirin in stable cardiovascular disease.N Engl J Med. 2017; 377: 1319-1330
- Rivaroxaban, aspirin, or both to prevent early coronary bypass graft occlusion: the COMPASS-CABG Study.J Am Coll Cardiol. 2019; 73: 121-130
- Skeletonized vs pedicled internal mammary artery graft harvesting in coronary artery bypass surgery: a post hoc analysis from the COMPASS trial.JAMA Cardiol. 2021; 6: 1042-1049
- Patency of skeletonized versus pedicled internal thoracic artery in coronary bypass graft surgery: a systematic review, meta-analysis and meta-regression.Int J Surg. 2014; 12: 666-672
- Comparison of long-term clinical outcomes of skeletonized vs pedicled internal thoracic artery harvesting techniques in the Arterial Revascularization Trial.JAMA Cardiol. 2021; 6: 1380-1386
- Off-pump versus on-pump coronary artery bypass surgery: graft patency assessment with coronary computed tomographic angiography.J Thorac Imaging. 2017; 32: 370-377
- Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.Circulation. 2014; 130: 1445-1451
- Radial artery as a coronary artery bypass conduit: 20-year results.J Am Coll Cardiol. 2016; 68: 603-610
- Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.JAMA. 2005; 294: 2446-2454
- On-pump versus off-pump coronary-artery bypass surgery.N Engl J Med. 2009; 361: 1827-1837
- Development of a risk score for early saphenous vein graft failure: an individual patient data meta-analysis.J Thorac Cardiovasc Surg. 2020; 160: 116-127.e114
- The effect of adding ticagrelor to standard aspirin on saphenous vein graft patency in patients undergoing coronary artery bypass grafting (POPular CABG): a randomized, double-blind, placebo-controlled trial.Circulation. 2020; 142: 1799-1807
- No-touch versus conventional vein harvesting techniques at 12 months after coronary artery bypass grafting surgery: multicenter randomized, controlled trial.Circulation. 2021; 144: 1120-1129
- The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.N Engl J Med. 1997; 336: 153-163
- Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis.BMJ. 2019; 367: l5476
- Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial.JAMA. 2018; 319: 1677-1686
- A systematic review and meta-analysis of multidetector computed tomography in the assessment of coronary artery bypass grafts.Int J Cardiol. 2016; 221: 898-905
Article info
Publication history
Published online: June 01, 2022
Accepted:
May 9,
2022
Received in revised form:
April 22,
2022
Received:
December 30,
2021
Footnotes
Clinical trial registry number (ClinicalTrials.gov Identifier: NCT01776424).
Identification
Copyright
© 2022 by The American Association for Thoracic Surgery
ScienceDirect
Access this article on ScienceDirectLinked Article
- Multiple and total arterial grafts are not a mirage anymore!JTCVS OpenVol. 13
- PreviewThe use of single arterial graft (SAG) is the most used technique for coronary artery bypass grafting (CABG), although a body of literature reports an increasing use of multiple (MAG) and total arterial graft (TAG).1,2 Unfortunately, the use of MAG/TAG is still underused, being reported between 10% and 35% in Europe and North America.3 Factors such as higher consuming time, greater prone to spasm, and technical harvesting lead surgeons to prefer SAG to MAG/TAG (Figure 1). In addition, the latest guidelines encourage percutaneous coronary intervention in 3-vessel coronary artery disease patients with limited coronary calcification and favor the use of CABG in patients with extensive coronary calcifications.
- Full-Text
- Preview
- Commentary: Conduit selection in the COMPASS trial: Pointing in the wrong direction?The Journal of Thoracic and Cardiovascular SurgeryVol. 165Issue 3
- PreviewThe Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) investigators report 1-year computed tomography angiography patency rates of 4 different coronary artery bypass graft conduits.1 In the overall study, 1068 patients received 3480 grafts, or an average of 3.3 grafts per patient.1 The operations were performed by more than 100 surgeons in 83 centers in 22 countries.1 Overall, there were 2239 saphenous vein grafts (SVGs) (64%), 1068 left internal thoracic artery (LITA) grafts (31%), 90 radial artery (RA) grafts (2.6%), and 82 right internal thoracic artery (RITA) grafts (2.4%).
- Full-Text
- Preview
